baber/WOPTO huggingface dataset:
Patent AU-2011302472-B2 (AU)
Title: Systems and methods for making and using electrode configurations for paddle leads
Inventor: PIANCA ANNE MARGARET
IPC: A61N1/34
Filed: 2011-09-02
Granted: 2016-03-10
Abstract: A paddle lead assembly for providing electrical stimulation of patient tissue includes a paddle body having a longitudinal axis and a lateral axis transverse to the longitudinal axis. The paddle body includes a plurality of electrodes disposed into at least four columns extending parallel with the longitudinal axis. The at least four columns include two lateral columns and at least two medial columns disposed therebetween. The electrodes of the at least two medial columns are arranged into rows aligned along the transverse axis. The electrodes of the two lateral columns are each longitudinally offset from the rows of electrodes of the at least two medial columns. An array of terminals are disposed on each of at least one lead body coupled to the paddle body. A plurality of conductive wires couple each of the electrodes to at least one terminal of the terminal arrays.
Patent AU-2011302866-B2 (AU)
Title: Fluid discharge device
Inventor: PARK EUNTAE
IPC: E03C1/042
Filed: 2011-09-08
Granted: 2015-12-24
Abstract: The present invention relates to the fluid discharge device of a fluid transfer pipe, and to a technology which alters the sectional area of a discharge hole in proportion to the increase or decrease in fluid discharge flow per unit of time so as to maintain a relatively uniform fluid discharge rate from the discharge hole.
Patent AU-2011318574-B2 (AU)
Title: Antibodies
Inventor: TERRETT JONATHAN ALEXANDER
IPC: C07K16/00
Filed: 2011-10-19
Granted: 2016-03-03
Abstract: The present disclosure provides antibodies, including isolated monoclonal antibodies, which specifically bind to CDH17 with high affinity. Nucleic acid molecules encoding CDH17 antibodies, expression vectors, host cells and methods for expressing CDH17 antibodies are also provided. Bispecific molecules and pharmaceutical compositions comprising the CDH17 antibodies are also provided. Methods for detecting CDH17, as well as methods for treating carious cancers, including gastric cancer, pancreatic cancer, colon cancer and colorectal cancer, are disclosed.
Patent AU-2011323791-B2 (AU)
Title: A hydraulic suspension system for lowering the ride height of a vehicle
Inventor: HOLDEN DAVID J
IPC: F16F9/00
Filed: 2011-10-25
Granted: 2015-11-05
Abstract: A hydraulic system for lowering the ride height of a vehicle includes at least one hydraulic shock mounted to the suspension of the vehicle. Each of the hydraulic shocks has a floating bearing in the hydraulic shock, and an inlet. The inlet is hydraulically connected to a central manifold that is adapted to move fluid into and out of the hydraulic shock for moving the floating bearing in each of the hydraulic shocks. When the floating bearing is moved in the hydraulic shock, the hydraulic shock shortens thereby lowering the ride height of the vehicle.
Patent AU-2011325247-B2 (AU)
Title: Medicated module with interlock
Inventor: DAVIES JAMES ALEXANDER
IPC: A61M5/31
Filed: 2011-10-31
Granted: 2015-01-22
Abstract: A medicated module attachable to a drug delivery device comprising a connecting body configured for attachment to the drug delivery device. A first needle held within a first needle hub of the connecting body and a second needle fixed within a second needle hub of the connecting body. A recess within the connecting body defining a reservoir. The reservoir containing at least one dose of a medicament and configured for fluid communication with the first needle. The connecting body further comprises a lockout feature that prevents the medicated module from being reconnected to the drug delivery device after the medicated module has been connected to the drug delivery device a first time.
Patent AU-2011331162-B2 (AU)
Title: Antibody with specificity for GM-CSF (I)
Inventor: MAGNENAT LAURENT
IPC: C07K16/24
Filed: 2011-11-17
Granted: 2016-07-07
Abstract: The present invention relates to antibodies with specificity for granulocyte- macrophage colony stimulating factor (GM-CSF). More particularly, the invention relates to humanized monoclonal antibodies that bind specifically to human GM-CSF with high affinity. The invention also relates to nucleic acids encoding the antibodies, vectors for expression of these nucleic acids, and host cells for producing said antibodies. Further, the invention relates to the use of said antibodies in the diagnosis or treatment of autoimmune or inflammatory diseases.
Patent AU-2011347274-B2 (AU)
Title: Catheter assembly and a method and system for producing such an assembly
Inventor: GUSTAVSSON EVELINA
IPC: A61M25/00
Filed: 2011-12-21
Granted: 2016-07-07
Abstract: A catheter assembly is disclosed, comprising a catheter (1), such as a urinary catheter, which at least a partly is provided with a hydrophilic coating (14). The catheter assembly further comprises a wetting fluid. The receptacle (2) is in direct contact with the hydrophilic coating of the catheter over essentially the entire length of the part of the catheter being provided with the hydrophilic coating. This may e.g. be achieved by using a shrink wrap material. In order to accomplish adequate wetting, channels (15, 151, 22, 221 ) or the like may be provided on the inner surface of the receptacle or the outer surface of the catheter.
Patent AU-2011349336-B2 (AU)
Title: Aqueous solution hydrolysis of cellulose followed by platinum catalyzed hydrodeoxydation of intermediate oxygenates to fuels
Inventor: POWELL JOSEPH BROUN
IPC: C10G3/00
Filed: 2011-12-20
Granted: 2015-08-13
Abstract: Biofuels can be produced by: (i) providing a biomass containing celluloses, hemicelluloses, lignin, nitrogen compounds and sulfur compounds; (ii) removing sulfur compounds and nitrogen compounds from the biomass by contacting the biomass with a digestive solvent to form a pretreated biomass containing carbohydrates and having less than 35% of the sulfur content and less than 35% of the nitrogen content of untreated biomass on a dry mass basis; (iii) contacting the pretreated biomass directly with hydrogen in the presence of a hydrogenolysis catalyst to form a plurality of oxygenated intermediates, and (vi) processing at least a portion of the oxygenated intermediates to form a liquid fuel.
Patent AU-2012202457-B2 (AU)
Title: Delta3- substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase ( PI3K) inhibitors
Inventor: CHEN YI
IPC: A61K31/4709
Filed: 2012-04-27
Granted: 2014-06-05
Abstract: Substituted bicyclic heteroaryls having the structure: (I) R" X R XIR 3 ( 5 or any pharmaceutically-acceptable salt thereof, wherein: X1 is C(R 9) or N; X2 is C(R' 0) or N; Y is N(R" 1), 0 or S; which are useful to inhibit the biological activity of human PI3K6 and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints 10 with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiple sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The 15 present invention also enables methods for treating cancers that are mediated, dependent on or associated with pI 10S activity, including but not restricted to ;Ieukemias, such as Acute Myeloid leukaemia (AML) Myelo- dysplastic syndrome (MDS), myeloproliferative diseases (MPD), Chronic Myeloid Leukemia (CML), T-cell Acute Lymphoblastic Leukaemia ( T-ALL), B-cell Acute Lymphoblastic Leukaemia (B-ALL), 20 Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
Patent AU-2012203448-B2 (AU)
Title: Gate valve seat and seat ring
Inventor: WOLFE CHRISTOPHER E
IPC: F16K1/16
Filed: 2012-06-13
Granted: 2016-12-15
Abstract: Abstract A gate valve (40) has a body (42), the body (42) having a cavity (45) and a flow passage (44) intersecting the cavity (45). A seat (50) is mounted to the body (42) at the intersection of the flow passage (44) and the cavity (45). A gate (46) is installed at the cavity (45) and has an engaging face (80) that slidingly engages the seat (50) while the gate is being moved between open and closed positions. The end faces (58,72) between a seat pocket and the seat are hard-coated (70, 74) and smooth-finished to provide sealing when mated. The hardcoated pocket and seat sealing surfaces (58,72) extend the life of the valve (40) by eliminating the need for an elastomeric seal of limited life. 56 46 1 92 94 70 _ _ 80-57 44 - 58- 60- ~~4 Fig. 3 -JI
Patent AU-2012204074-B2 (AU)
Title: System for integrated analysis of real-time polymerase chain reaction and DNA chip and method for integrated analysis using the same
Inventor: SEO SUNG-MIN
IPC: C12Q1/68
Filed: 2012-07-10
Granted: 2015-06-25
Abstract: Provided are a system for integrated analysis of a real-time polymerase chain reaction and a DNA chip and a method for integrated analysis using the same, and more 5 particularly to an apparatus for integrated analysis of a real-time polymerase chain reaction and a DNA chip and a method for integrated analysis using the same. According to the method for integrated analysis of a biomaterial of the present invention, gene amplification proceeds and 10 subsequently hybridization proceeds in a single reactor, thereby preventing contamination of the sample due to external factors, which may be caused while the sample is transferred for reaction, and automating a series of procedures such as injection of the sample, reaction of the 15 biomaterial, and detection and analysis of results.
Patent AU-2012230279-B2 (AU)
Title: Cytological method using the auto fluorescence of white corpuscles for the early diagnosis and the monitoring of infections
Inventor: ASEHNOUNE KARIM
IPC: G01N21/64
Filed: 2012-03-22
Granted: 2015-07-16
Abstract: The present invention relates to an in vitro method for diagnosing the infectious state of an individual on the basis of a sample of white corpuscles arising from a biological specimen taken from an organ potentially infected by a pathogenic micro-organism of said individual, comprising at least the following two steps: i) measuring the mean cellular intensity of the autofluorescence of said sample, and ii) comparing the intensity measured in step i) with a control value, so as to determine the infectious state of said individual. The diagnostic method of the invention uses a routine optical material making it possible to work in wavelength regions which are compatible with the cellular autofluorescence, and thus constitutes a rapid, reliable and inexpensive aid for the diagnosis or monitoring of an infection in an individual.
Patent AU-2012245491-B2 (AU)
Title: Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
Inventor: BAUM JASON
IPC: C07K16/28
Filed: 2012-04-19
Granted: 2017-08-17
Abstract: Provided herein are novel monospecific and bispecific antibodies that are useful as anti neoplastic agents and that bind specifically to human IGF-IR and human ErbB3. Exemplary antibodies inhibit signal transduction through either or both of IGF-IR and ErbB3. Exemplary polyvalent proteins comprise at least one anti-IGF-lR binding site and at least one anti-ErbB3 binding site. In certain embodiments the binding sites may be linked through an immunoglobulin constant region. Novel antiErbB3 and anti-IGF-lR antibodies (e.g., monoclonal antibodies) are also provided.
Patent AU-2012258765-B2 (AU)
Title: Programmable control for siren and lights
Inventor: MILLER DANIEL S
IPC: B60Q1/52
Filed: 2012-05-23
Granted: 2015-05-07
Abstract: A system comprising a power supply, an emergency warning light and a speaker, in combination with a control head. One or more processors controls operation of the system in response to recevied user input and provides system status for display. Storage media encoded with emergency warning light system instructions for execution by one ore more of the processors controls the actuation of the emergency warning light system and controls light patterns generated by the emergency warning light system. The storage media is further encoded with siren system instructions for execution by one or more of the processors for controlling the actuation of the siren system and for controlling audible sounds generated by the siren system.
Patent AU-2012264943-B2 (AU)
Title: Means and methods for diagnosing and treating multiple sclerosis
Inventor: HEMMER BERNHARD
IPC: C07K14/47
Filed: 2012-05-23
Granted: 2016-12-15
Abstract: This invention relates to a peptide comprising or consisting of at least 8 consecutive amino acid residues of the sequence set forth in SEQ ID NO: 3, provided that said peptide does not consist of the sequence set forth in SEQ ID NO: 3, or a corresponding peptidomimetic, wherein said peptide or peptidomimetic binds to an anti-KIR4.1 antibody comprised in a sample from a patient, said patient having multiple sclerosis or a predisposition therefor, wherein preferably (i) said at least 8 consecutive amino acid residues are a subsequence of an extracellular domain of KIR4.1, said extracellular domain consisting of the sequence set forth in SEQ ID NO: 1 or 2; or (ii) said peptide comprises or consists of the sequence of SEQ ID NO: 1 or 2. The present invention furthermore relates to a method for diagnosing multiple sclerosis or a predisposition for multiple sclerosis in a subject, the method comprising determining the presence of an anti-KIR4.1 antibody in a sample obtained from said subject, wherein the presence of an anti-KIR4.1 antibody in said sample is indicative of multiple sclerosis or a predisposition for multiple sclerosis. Also provided are novel means and methods for the therapy of multiple sclerosis.
Patent AU-2012285550-B2 (AU)
Title: Seismic geophysical surveying using a fibre optic distributed sensing apparatus
Inventor: LEWIS ANDREW
IPC: G01V1/22
Filed: 2012-07-12
Granted: 2015-09-24
Abstract: The present invention relates to an apparatus for use in geophysical surveying. Geophysical surveying typically involves stimulating an area of interest with a seismic source (204)and detecting the response in a sensor array. The application describes a fibre optic distributed sensing apparatus having a source(112)of electromagnetic radiation for repeatedly launching interrogating electromagnetic radiation into an optic fibre(104) deployed in said of area interest,a sampling detector (116) for sampling radiation back- scattered from the fibre; and a processor(108)arranged to process the back-scattered radiation to provide, for each of a plurality of longitudinal sensing portions of optic fibre, an indication of any incident acoustic signals affecting that sensing portion. The sampling detector is arranged to acquire a plurality of diversity samples for each said longitudinal sensing portion. The processor is configured process the diversity samples in diversity channels to determine a measurement signal indicative of any acoustic disturbance; correlate the measurement signal from each channel with a signal indicative of the seismic stimulus applied; and combine the correlated measurement signals to provide an overall measurement signal for the longitudinal sensing portion. The processor may apply a quality metric to the correlated data before performing the combination based on the quality metric. By correlating the individual diversity channels with the stimulus signal prior to performing the analysis of the measurement signal for a particular longitudinal section of optic fibre, the signal to noise ratio can be improved.
Patent AU-2012290796-B2 (AU)
Title: Sandboxing technology for webruntime system
Inventor: BLAICH ANDREW C
IPC: G06F21/10
Filed: 2012-07-31
Granted: 2016-11-03
Abstract: In a first embodiment of the present invention, a method of providing security enforcements of widgets in a computer system having a processor and a memory is provided, comprising: extracting access control information from a widget process requesting a service, generating access control rules customized for the widget process, and providing the access control rules to a trusted portion of the computer system outside of the user code space of a Web Runtime (WRT) system; and for any static access control rule, delegating security checking of the widget process from the WRT system to the trusted portion of the computer system.
Patent AU-2012306503-B2 (AU)
Title: Heat insulated apparatus for heating smokable material
Inventor: EGOYANTS PETR ALEXANDROVICH
IPC: A24F40/20
Filed: 2012-08-24
Granted: 2016-01-28
Abstract: An apparatus configured to heat smokeable material to volatilize at least one component of the smokeable material, wherein the apparatus comprises a region insulation having a core region which is evacuated to a lower pressure than an exterior of the insulation.
Patent AU-2012354658-B2 (AU)
Title: Method for producing cooked and frozen pasta
Inventor: IRIE KENTAROU
IPC: A23L7/109
Filed: 2012-12-21
Granted: 2016-05-12
Abstract: Provided is a cooked and frozen pasta which can be stored in a frozen state over a long time and, after thawing, exhibits a good appearance and good texture comparable to freshly cooked fresh pasta. A method for producing a cooked and frozen pasta characterized by comprising extruding a dough under a pressure of 80-200 kgf/cm
Patent AU-2012355476-B2 (AU)
Title: Hemostatic materials and devices with galvanic particulates
Inventor: WANG YI-LAN
IPC: A61K31/715
Filed: 2012-12-17
Granted: 2016-12-22
Abstract: The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC.
Patent AU-2013202728-B2 (AU)
Title: Manipulation of flowering and plant architecture (4)
Inventor: SAWBRIDGE TIMOTHY IVOR
IPC: C12N15/29
Filed: 2013-04-05
Granted: 2017-01-05
Abstract: The present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences for proteins involved in the control of plant life cycles and/or growth phases, flowering processes, flowering and/or plant architecture, and/or inflorescence and/or flower development in plants, and the use thereof for the modification of plant life cycles and/or growth phases, flowering processes, flowering and/or plant architecture, and/or inflorescence and/or flower development in plants.
Patent AU-2013203045-B2 (AU)
Title: System for capturing and modifying large pieces of genomic DNA and constructing organisms with synthetic chloroplasts
Inventor: MENDEZ MIKE
IPC: C07H21/04
Filed: 2013-04-03
Granted: 2014-06-19
Abstract: The functional analysis of genes frequently requires the manipulation of large genomic regions. A yeast-bacteria shuttle vector is described that can be used to clone large regions of DNA by homologous recombination. Also described is a method for isolating entire genomes, including 5 chloroplast genomes, or large portions thereof, and manipulating the same. Also described are methods for determining minimal genomes, minimal pathway requirements, and minimal organelle genomes.
Patent AU-2013207132-B2 (AU)
Title: An apparatus and a method for psychiatric evaluation
Inventor: BENSON PHILIP
IPC: A61B5/16
Filed: 2013-01-07
Granted: 2018-05-10
Abstract: Apparatus (1) for use in a method for psychiatric evaluation comprises: memory means (4) for holding a store of pre-selected images; display means (12) for displaying a succession of said images to a patient; eye tracking means (6) for tracking eye movement of a patient; recording means (8) for recording eye movement data corresponding to a patient's eye movement in response to the display of said succession of images; control means (2) for controlling the display means to display the images to the patient, and for controlling the recording means to record said eye movement data and displayed image data; and evaluation means (10) for evaluating said eye movement data and displayed image data for use in identifying a psychiatric profile of the patient.
Patent AU-2013217038-B2 (AU)
Title: Systems and methods of detecting, measuring, and extracting signatures of signals embedded in social media data streams
Inventor: BLASCHAK JEFFREY G
IPC: G06F17/27
Filed: 2013-02-07
Granted: 2018-05-17
Abstract: A system for scoring micro-blogging messages is provided, including an extractor, and evaluator, a calculator, and a publisher. The extractor may be configured to receive micro-blogging messages, to detect messages containing terms of interest, to extract raw data, and to store the data in a database. The evaluator may be configured to access and parse the stored data into tokenized data, and to store the tokenized data in a database. The evaluator may also be configured to identify relevant micro-blogging messages; to tag message as indicative; and to filter messages from low- volume or malicious sources before being tagged as indicative. The calculator may be configured to access a sentiment dictionary; to calculate a sentiment score of the tokenized data, and to calculate a sentiment signature for a term of interest. The publisher may be configured to provide access to clients of the system.
Patent AU-2013232034-B2 (AU)
Title: Permittivity shielding
Inventor: BOEDECKER VOLKER
IPC: A61B5/00
Filed: 2013-03-14
Granted: 2017-02-02
Abstract: Techniques for shielding permittivity-sensitive devices are disclosed.
Patent AU-2013260061-B2 (AU)
Title: Methods and materials to enhance high temperature rheology in invert emulsions
Inventor: WAGLE VIKRANT BHAVANISHANKAR
IPC: C09K8/36
Filed: 2013-03-17
Granted: 2015-07-09
Abstract: An invert emulsion drilling fluid, and a method of drilling with such fluid, having improved rheology at low mud weights and high temperatures. The improved rheology is effected with addition of a rheology additive of the invention comprising fatty dimer diamines or dimer diamines and an organic acid or ester of the acid. A nonlimiting example of such a rheology additive comprises a C36 fatty dimer diamine and adipic acid or dimethyl adipate.
Patent AU-2013262515-B2 (AU)
Title: Methods for treating or predicting risk of a ventricular tachyarrhythmia event
Inventor: SNIDER JAMES V
IPC: A61K35/14
Filed: 2013-05-17
Granted: 2018-03-15
Abstract: Provided herein are methods that include (i) determining a level of soluble ST2 in a biological sample from a subject, (i) comparing the level of soluble ST2 in the biological sample to a reference level of soluble ST2 (e.g., a level of soluble ST2 in the subject at an earlier time point), and (iii) selecting, implanting, replacing, or reprogramming an implanted cardiac device, e.g., an ICD, CRT, or CRT-D device, for a subject having an elevated level of soluble ST2 in the biological sample compared to the reference level of soluble ST2, or selecting a subject for participation in, or stratifying a subject participating in, a clinical study of a treatment for reducing the risk of a ventricular tachyarrhythmia (VTA) event. Also provided are methods for evaluating the risk of a VTA event in a subject. Also provided are kits for performing any of these methods.